期刊论文详细信息
Endocrine Journal
Normal Growth and Pubertal Development During Bromocriptine Therapy in Two Patients with Prolactinoma
ALI RIZA UYSAL1  NILCÜN BASKAL1  NURI KAMEL1  VEDIA CESUR1  GÜRBÜZ ERDOAN1 
[1] Endocrinology and Metabolic Diseases Department, Ankara University, School of Medicine
关键词: Bromocriptine;    Puberty;    Prolactinoma;   
DOI  :  10.1507/endocrj.42.581
学科分类:内分泌与代谢学
来源: Japan Endocrine Society
PDF
【 摘 要 】

References(25)Cited-By(2)The cases of two boys, a 14 years 10 months old and an 18-year-old, with delayed puberty are presented. The first patient also had a short stature. Both patients had a pituitary adenoma, as shown by computed tomography, with high prolactin levels. After bromocriptine therapy was started, there was a spontaneous progression of normal puberty. The first patient used a synthetic growth hormone together with bromocriptine, however, even after the growth hormone was stopped progression in puberty and gain in height continued. The favorable response obtained in these patients implies that bromocriptine can be an effective therapy for adolescent patients with prolactinoma.

【 授权许可】

Unknown   

【 预 览 】
附件列表
Files Size Format View
RO201911300759111ZK.pdf 770KB PDF download
  文献评价指标  
  下载次数:5次 浏览次数:5次